| Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents R Bedimo, NM Maalouf, S Zhang, H Drechsler, P Tebas Aids 26 (7), 825-831, 2012 | 392 | 2012 |
| Non-HACEK gram-negative bacillus endocarditis S Morpeth, D Murdoch, CH Cabell, AW Karchmer, P Pappas, D Levine, ... Annals of internal medicine 147 (12), 829-835, 2007 | 305 | 2007 |
| Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from … MS Freiberg, CCH Chang, M Skanderson, OV Patterson, SL DuVall, ... JAMA cardiology 2 (5), 536-546, 2017 | 280 | 2017 |
| Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel RT Gandhi, R Bedimo, JF Hoy, RJ Landovitz, DM Smith, EF Eaton, ... Jama 329 (1), 63-84, 2023 | 258 | 2023 |
| Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression RJ Bedimo, KA McGinnis, M Dunlap, MC Rodriguez-Barradas, AC Justice JAIDS Journal of Acquired Immune Deficiency Syndromes 52 (2), 203-208, 2009 | 258 | 2009 |
| A multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis RF Betts, M Nucci, D Talwar, M Gareca, F Queiroz-Telles, RJ Bedimo, ... Clinical infectious diseases 48 (12), 1676-1684, 2009 | 249 | 2009 |
| HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction AL Paisible, CCH Chang, KA So-Armah, AA Butt, DA Leaf, M Budoff, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (2), 209-216, 2015 | 229 | 2015 |
| Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans A Colpan, B Johnston, S Porter, C Clabots, R Anway, L Thao, ... Clinical infectious diseases 57 (9), 1256-1265, 2013 | 223 | 2013 |
| Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era RJ Bedimo, AO Westfall, H Drechsler, G Vidiella, P Tebas Clinical Infectious Diseases 53 (1), 84-91, 2011 | 182 | 2011 |
| MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the … L Ostrosky-Zeichner, S Shoham, J Vazquez, A Reboli, R Betts, MA Barron, ... Clinical infectious diseases 58 (9), 1219-1226, 2014 | 178 | 2014 |
| Microvascular disease, peripheral artery disease, and amputation JA Beckman, MS Duncan, SM Damrauer, QS Wells, JV Barnett, ... Circulation 140 (6), 449-458, 2019 | 162 | 2019 |
| Trends in AIDS-Defining and Non—AIDS-Defining Malignancies among HIV-Infected Patients: 1989–2002 R Bedimo, RY Chen, NA Accortt, JL Raper, C Linn, JJ Allison, J Dubay, ... Clinical Infectious Diseases 39 (9), 1380-1384, 2004 | 159 | 2004 |
| Hepatitis c virus coinfection and the risk of cardiovascular disease among hiv‐infected patients R Bedimo, AO Westfall, M Mugavero, H Drechsler, N Khanna, M Saag HIV medicine 11 (7), 462-468, 2010 | 150 | 2010 |
| Validated risk score for predicting 6‐month mortality in infective endocarditis LP Park, VH Chu, G Peterson, A Skoutelis, T Lejko‐Zupa, E Bouza, ... Journal of the American Heart Association 5 (4), e003016, 2016 | 146 | 2016 |
| Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin AJ Busti, AM Bain, RG Hall, RG Bedimo, RD Leff, C Meek, R Mehvar Journal of cardiovascular pharmacology 51 (6), 605-610, 2008 | 130 | 2008 |
| A school-based chlamydia control program using DNA amplification technology DA Cohen, M Nsuami, RB Etame, S Tropez-Sims, S Abdalian, TA Farley, ... Pediatrics 101 (1), e1-e1, 1998 | 129 | 1998 |
| Impact of Early Valve Surgery on Outcome of Staphylococcus aureus Prosthetic Valve Infective Endocarditis: Analysis in the International Collaboration of … C Chirouze, F Alla, VG Fowler Jr, DJ Sexton, GR Corey, VH Chu, A Wang, ... Clinical Infectious Diseases 60 (5), 741-749, 2015 | 119 | 2015 |
| Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence … MJ Cenizal, D Skiest, S Luber, R Bedimo, P Davis, P Fox, K Delaney, ... Antimicrobial agents and chemotherapy 51 (7), 2628-2630, 2007 | 118 | 2007 |
| Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study K Sigel, J Wisnivesky, K Crothers, K Gordon, ST Brown, D Rimland, ... The lancet HIV 4 (2), e67-e73, 2017 | 104 | 2017 |
| Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257 I Ofotokun, LH Na, RJ Landovitz, HJ Ribaudo, GA McComsey, C Godfrey, ... Clinical Infectious Diseases 60 (12), 1842-1851, 2015 | 98 | 2015 |
